Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model

This Phase II study evaluated analgesia, abuse liability, and cognitive performance of hydromorphone and oral delta-9-tetrahydrocannabinol (THC; dronabinol) using a within-subject, double-blind, randomized, placebo-controlled, human laboratory trial. Healthy adults (N = 29) with no history of drug u...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunn, Kelly E., Bergeria, Cecilia L., Huhn, Andrew S., Speed, Traci J., Mun, Chung Jung, Vandrey, Ryan, Campbell, Claudia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055479/
https://www.ncbi.nlm.nih.gov/pubmed/33879842
http://dx.doi.org/10.1038/s41386-021-01007-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055479/
https://www.ncbi.nlm.nih.gov/pubmed/33879842
http://dx.doi.org/10.1038/s41386-021-01007-4

Ejemplares similares